search
Back to results

Acceptability of HPV Self-sampling Among Canadian Women Aged 21 to 65 (CUTE-IPS)

Primary Purpose

HPV Infection, Cervical Cancer Screening

Status
Active
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
HPV self-sampling
Sponsored by
Université de Sherbrooke
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional screening trial for HPV Infection

Eligibility Criteria

21 Years - 65 Years (Adult, Older Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • Speak and understand French without help

    • Have internet access (for completing forms)
    • Have a mailing address

Exclusion Criteria:

  • Known positive HPV status • Have already had a hysterectomy

Sites / Locations

  • Centre Hospitalier Universitaire de Sherbrooke

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

HPV self-sampling group

Arm Description

Outcomes

Primary Outcome Measures

Evaluate the acceptability of HPV self-sampling by patients
percentage of patients who prefer HPV testing to traditional cytology

Secondary Outcome Measures

Evaluate the percentage of samples collected correctly by patients
Evaluate the return rate of mailed kits
Calculate the HPV positivity rate in a population sample

Full Information

First Posted
March 10, 2022
Last Updated
June 7, 2022
Sponsor
Université de Sherbrooke
search

1. Study Identification

Unique Protocol Identification Number
NCT05414929
Brief Title
Acceptability of HPV Self-sampling Among Canadian Women Aged 21 to 65
Acronym
CUTE-IPS
Official Title
Prévention du Cancer du Col de l'UTÉrus Par dépistage d'Une Infection Partageable Sexuellement
Study Type
Interventional

2. Study Status

Record Verification Date
June 2022
Overall Recruitment Status
Active, not recruiting
Study Start Date
April 4, 2022 (Actual)
Primary Completion Date
May 15, 2022 (Actual)
Study Completion Date
June 30, 2022 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Université de Sherbrooke

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
We propose a cross-sectional study to explore the acceptability and feasibility of HPV self-sampling among Quebec women. The study will invite eligible women to self-sample for HPV at home. The HPV risk factors of patients included in the study will be taken into consideration (vaccination, smoking, number of partners, date of last screening, etc.).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
HPV Infection, Cervical Cancer Screening

7. Study Design

Primary Purpose
Screening
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
400 (Actual)

8. Arms, Groups, and Interventions

Arm Title
HPV self-sampling group
Arm Type
Experimental
Intervention Type
Diagnostic Test
Intervention Name(s)
HPV self-sampling
Intervention Description
HPV self-sampling (Cobas Uniswab)
Primary Outcome Measure Information:
Title
Evaluate the acceptability of HPV self-sampling by patients
Description
percentage of patients who prefer HPV testing to traditional cytology
Time Frame
2 months following recruitment
Secondary Outcome Measure Information:
Title
Evaluate the percentage of samples collected correctly by patients
Time Frame
2 months following recruitment
Title
Evaluate the return rate of mailed kits
Time Frame
2 months following recruitment
Title
Calculate the HPV positivity rate in a population sample
Time Frame
2 months following recruitment

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
21 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Speak and understand French without help Have internet access (for completing forms) Have a mailing address Exclusion Criteria: Known positive HPV status • Have already had a hysterectomy
Facility Information:
Facility Name
Centre Hospitalier Universitaire de Sherbrooke
City
Sherbrooke
State/Province
Quebec
ZIP/Postal Code
j1n4j6
Country
Canada

12. IPD Sharing Statement

Learn more about this trial

Acceptability of HPV Self-sampling Among Canadian Women Aged 21 to 65

We'll reach out to this number within 24 hrs